Psychiatric News (8/27) reports a study found that “individuals with opioid use disorder (OUD) treated in primary care with a collaborative care model (CoCM) focused on medications for OUD experienced a greater reduction in nonmedical use of opioids than those receiving collaborative care that only treats co-occurring mental health symptoms.” Researchers found that “at three months, patients receiving the OUD-focused CoCM had an average of 1.44 days using opioids compared with 3.98 days among those receiving standard CoCM; at six months, patients in the intervention group had 0.72 days using opioids compared with 3.92 days in the control group. Scores on the MCS improved in both groups, but there was no statistical difference.” The study was published in JAMA Psychiatry.

Related Links:

— “Collaborative Care for Opioid Use Disorder in Primary Care,” John C. Fortney, PhD; Anna D. Ratzliff, MD, PhD; Brittany E. Blanchard, PhD, JAMA Psychiatry, August 20, 2025

HealthDay (8/26, Solomon) reports, “Few teens with depression receive treatment, with disparities seen based on residence, gender, and race, according to a study.” The investigators “found that 19.2 percent of adolescents experienced [major depressive episodes], but only 47.5 percent received treatment within the past year.” Researchers found “there were significantly lower odds of receiving specialist treatment for adolescents in rural areas versus their urban counterparts.” The findings were published in PLOS Mental Health.

Related Links:

— “Less Than Half of Teens With Major Depression Receive Treatment,” Lori Solomon, HealthDay, August 26, 2025

Modern Healthcare (8/26, Perna, Subscription Publication) reports, “State legislators are moving quickly to regulate artificial intelligence in healthcare, particularly in the mental health arena.” With “federal legislation of AI unlikely during President…Trump’s administration, states are moving ahead with their own laws as the hype over the technology permeates all areas of healthcare.” States such as “Illinois, Nevada and Texas have already passed a handful of laws.” According to Modern Healthcare, “consulting firm Manatt Health said there are more than 250 additional AI bills under consideration across 46 states that could use these early adopters as a roadmap.”

Related Links:

— “States move legislation on AI-enabled mental health, prior auth,” Gabriel Perna, Modern Healthcare, August26 , 2025

Psychiatric News (8/26) reports “more than 70% of mental health apps do not mention any crisis hotline, and only one in seven mentions the 988 Suicide and Crisis Lifeline, a study” found. The research also found that “a sizable minority of apps that mention alternative crisis hotlines link to ones that don’t work.” The findings were published in Psychiatric Services.

Related Links:

— “Mental Health Apps and Crisis Support: Exploring the Impact of 988,” Bridget Dwyer, B.S., Jane Mikkelson, B.A., James Burns, B.S., Valeria Diaz-Pacheco, B.S., M.S., and John Torous, M.D., M.B.I., Psychiatric Services, August 21, 2025

The New York Times (8/25, Hoffman) reports, “As fentanyl propelled overdose deaths to ever more alarming numbers several years ago, public health officials throughout the United States stepped up a blunt, pragmatic response.” More states “authorized needle exchanges, where drug users could get sterile syringes as well as alcohol wipes, rubber ties and cookers.” As a result, “by mid-2023, overdose deaths began dropping.

Last year, there were an estimated 80,391 drug overdose deaths in the United States, down from 110,037 in 2023, according to provisional data from the Centers for Disease Control and Prevention.” However, “states and communities are turning away from harm reduction strategies” after President Trump last month issued an “executive order that included a blast at harm reduction programs.”

Related Links:

— The New York Times (requires login and subscription)

MedPage Today (8/25, Firth) reports a systematic review and meta-analysis of 99 studies found that “cannabis products containing high concentrations of delta-9-tetrahydrocannabinol (THC) – the main psychoactive compound in marijuana – were linked to psychosis, schizophrenia, and addiction.” Researchers observed that “70% of the nontherapeutic studies (i.e., those not attempting to treat a medical condition or symptom) showed an unfavorable association with psychosis or schizophrenia and 75% found a relationship to cannabis use disorder (CUD).

Anxiety and depression appeared to be worsened in 53% and 41% of such studies, respectively, with even higher rates when studying healthy individuals specifically.” The researchers noted the findings complement those of prior systematic reviews in “reinforcing the conclusion that higher THC concentrations increase the risk for adverse mental health outcomes.” The review was published in Annals of Internal Medicine.

Related Links:

— MedPage Today (requires login and subscription)

Psychiatric News (8/22) reported a study found that “nonfatal firearm injuries raise the risk of mental and substance use disorders (SUD).” The researchers used data from Marketscan “to compare claims from 2007 with claims from 2019.” They observed “a higher prevalence of diagnoses before injury among survivors but not among family members relative to controls.” Specifically, they found that “after nonfatal firearm injury, psychiatric disorders increased among survivors, including 77% for mood disorders, 146% for trauma-related disorders, 57% for anxiety disorders, and 73% to 305% for psychotic, neuropsychiatric, and other disorders.” They also found that SUD diagnoses “rose after firearm injury, including 99% for tobacco use disorder, 186% for alcohol use disorder, and 49% to 195% for opioid, cannabis, sedative, stimulant, and other substance use disorders.” The study was published in JAMA Psychiatry.

Related Links:

— “Psychiatric and Substance Use Disorders After Nonfatal Firearm Injury,” Katherine A. Koh, MD, MSc1; Mia Giuriato, BBA, MA3; Chana A. Sacks, MD, MPH JAMA Psychiatry, August 20, 2025 (Access Required)

HealthDay (8/22, Thompson) reported a study found that “local parks and neighborhood greenery protected people’s mental health from the stresses of the COVID-19 pandemic.” Researchers noted that “depression increased nearly two-fold during the pandemic, with both men and women more frequently diagnosed,” but observed that “middle-aged adults and seniors had a reduced risk of depression if they lived in greener neighborhoods.” Furthermore, they found that “the greener a person’s neighborhood, the lower their risk for depression.” Researchers concluded, “Our findings suggest that green spaces may have played a modest, yet meaningful, role in supporting the mental well-being of lower-income Canadians during the pandemic, offering some relief amid deepening socio-economic inequities.” The study was published in PLOS One.

Related Links:

— “Green Spaces Provided Pandemic Protection Against Depression, Study Says,” Dennis Thompson, HealthDay, August 22, 2025

Healio (8/22, Laboy) reported a study found that “suicide and overdose rates notably increased at the onset of the 2023 Maui wildfires in Hawaii.” The researchers “analyzed suicide or overdose-related deaths in five Hawaii counties, including Maui, from January 2014 to December 2023.”

They found that “August 2023 was independently associated with a 97% increase in suicide and overdose rates in Maui alone and a 46% increase in both rates across counties. When suicide and overdose were analyzed separately, only the suicide rates were significantly higher in Maui compared to the other counties.”

According to Healio, “the findings indicate an immediate correlation between behavioral health outcomes and wildfires, suggesting a need for tailored interventions and protocols in the wake of natural disasters, the researchers wrote.” The study was published in JAMA.

Related Links:

— “Suicide, overdose rates increased in immediate wake of Maui wildfires,” Lucas Laboy, Healio, August22 , 2025

MedPage Today (8/21, Henderson) reports a survey study from two academic medical centers suggested that “passive documentation of clinic visits using artificial intelligence (AI)-drafted notes was linked to reduced burnout and improved well-being.” According to the survey, clinicians at Mass General Brigham Hospital in Boston who used the “system, dubbed ambient documentation technology (ADT), had a 21.2% absolute reduction in burnout.”

Likewise, clinicians at Emory Healthcare in Atlanta “showed a 30.7% absolute increase in documentation-related well-being, albeit with low survey response rates at both centers.” Researchers noted that “free-text survey responses included some users saying that ADT improved their clinic experience and subjective patient experience.” They concluded, “Documentation burden has been associated with clinician burnout, which is why there has been much interest in using technology solutions.” The study was published in JAMA Network Open.

Related Links:

— MedPage Today (requires login and subscription)